General MedicationsORALGeneric
TRISORALEN
TRIOXSALEN
Standard Dose
5MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview TRISORALEN is listed in Drugs@FDA under application 012697 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient TRIOXSALEN Form and strength TABLET;ORAL - 5MG Sponsor VALEANT PHARM INTL Submission history Latest submission status date: 1997-09-23 00:00:00.
Structured Monograph
Clinical summary
Approval overview TRISORALEN is listed in Drugs@FDA under application 012697 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient TRIOXSALEN Form and strength TABLET;ORAL - 5MG Sponsor VALEANT PHARM INTL Submission history Latest submission status date: 1997-09-23 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.